Stockscreener 앱 받기
5.80
2.11%
0.12
Intercure Ltd 주식(INCR)의 최신 뉴스
Intercure (INCR) Chart: Adds 0.23% to Close at $0.87 in the Current Update; Technical Setup: Traders Can Monitor the $0.83-$0.91 Range in Latest TradingMax Pain Level - dars.gov.et
InterCure announces 1-for-5 reverse stock split starting Monday By Investing.com - Investing.com Australia
Intercure (NASDAQ: INCR) issues stock for ISHI deal's first closing - Stock Titan
BRIEF-Intercure Ltd. Announces 1-For-5 Reverse Share Split - Bitget
InterCure announces 1-for-5 reverse stock split starting Monday - Investing.com
InterCure Ltd. Announces 1-for-5 Reverse Share Split - The Manila Times
Intercure Ltd. (INCR) Slips to $0.96: Support Test Looms as Cannabis Stock Faces PressureRVOL Spike - dars.gov.et
InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alon Shmuel Granot Net Worth (2026) - GuruFocus
InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting - TipRanks
InterCure holds extraordinary shareholder meeting - Bitget
InterCure Ltd. (INCR) shareholders back proposal at August 11, 2026 special meeting - Stock Titan
Intercure (INCR) Advances 5.91% to $0.98, Approaching Key Resistance at $1.03Factor Crowding - vinanet.vn
InterCure Ltd (INCR) Stock News Today - TradingKey
InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intercure Ltd. Ordinary Shares Share Price Live Today – NASDAQ:INCR Stock Price, Chart, News, History - Upstox
Intercure (INCR) Slips 1.16% to $0.95, Hovering Above Key SupportRVOL Spike - dars.gov.et
Intercure Details Voting Procedures for August 11 Extraordinary Shareholder Meeting - TipRanks
InterCure (INCR) sets voting process for August 11 extraordinary shareholder meeting - Stock Titan
INCR Q2 2023 Earnings: EPS Surprises to the Upside Despite Stock DeclineAdjusted Earnings Analysis - vinanet.vn
InterCure Ltd. Revenue Breakdown – TASE:INCR - TradingView
InterCure Ltd (INCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InterCure Ltd (INCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InterCure Ltd (INCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InterCure Ltd (INCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InterCure Ltd (INCR) Income Statement - TradingKey
INCR|InterCure Ltd|Price:0.939|Chg%:-0.020 - TradingKey
INCR|InterCure Ltd|Price:0.927|Chg%:+0.025 - TradingKey
InterCure Ltd (INCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
INCR Q2 2023 Earnings: EPS Surprises to the Upside as Profitability Exceeds ExpectationsHealthcare Earnings Report - vinanet.vn
What Is Driving InterCure (NASDAQ:INCR) on the Nasdaq? - Kalkine Media
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% as Stock GainsRevenue Growth Outlook - dars.gov.et
InterCure (INCR) seeks approval for 5-for-1 reverse share split - Stock Titan
Alexander Rabinovich Net Worth (2026) - GuruFocus
Lennie Grinbaum Michelson Net Worth (2026) - GuruFocus
INCR Q2 2023 Earnings: EPS Surprise Beats Estimates Amid Undisclosed RevenueAnnual Earnings Summary - vinanet.vn
Price to book forward of Intercure Ltd. – NASDAQ:INCR - TradingView
ETFs Investing in InterCure Ltd. Stocks - TradingView
Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into FocusFibonacci Entry Signals - dars.gov.et
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Surges Past Estimates with 28.68% SurpriseCost Structure Review - dars.gov.et
InterCure Ltd. Actuals & Estimates (TASE:INCR) - TradingView
Price to earnings forward of InterCure Ltd. – TASE:INCR - TradingView
InterCure Ltd. Actuals & Estimates (BOATS:INCR) - TradingView
Intercure (INCR) Sees Modest Decline, Tests Key Support Near $1.00Dark Pool Sentiment - po-news-eg.net
Price to sales forward of InterCure Ltd. – TASE:INCR - TradingView
Enterprise value to EBITDA forward of InterCure Ltd. – TASE:INCR - TradingView
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue PictureEnergy Earnings Report - dars.gov.et
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - Sahm
InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion - The Globe and Mail
InterCure secures $7.4M funding commitment, may rise to $18.6M - Investing.com UK
InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. - marketscreener.com
InterCure secures $7.4M funding commitment, may rise to $18.6M By Investing.com - Investing.com South Africa
InterCure (NASDAQ: INCR) lines up NIS 22–54 million private placement funding - Stock Titan
InterCure raises NIS 22M, with room to reach NIS 54M - Stock Titan
InterCure Ltd (INCR) Institutional Confidence - TradingKey
InterCure Ltd (INCR) Valuation: PE, PB & Fair Value Analysis - TradingKey
2.29%
자본화:
|
볼륨(24시간):